Introduction & Contents

Introduction

The microbiome therapeutics field still has a journey ahead before delivering a globally approved product. What more can be done to further prepare the biopharmaceutical industry and clinical understanding for production of microbiome-based therapies? This exclusive Microbiome Therapeutics eBook reviews the story so far, the biggest challenges that the industry is yet to overcome, and the most urgent opportunities for innovation.

The following pages deliver an overview of the existing regulatory landscape, lessons learned in standardising manufacturing, and the current demands for technologies in research and development.

Contents

1. Whitepaper: The Regulatory Environment of Microbiome-Based Therapies in the US & EU

2. Where Are the Biggest Gaps with Current Technologies to Understand Complex Interactions?

3. Whitepaper: Standardization and Opportunities in Manufacturing Microbiome Therapeutics

4. Are Standards for Manufacturing Microbiome Therapeutics Really Far Off?

Jump to any article using the contents on the right, or at any time using the Contents menu in the top left. There you can also download this eBook as a PDF.